Tom's Blog on Life

Paxil (for depression) and tamoxifen (for breast cancer) are a very bad mix.

The nearly 30 month survey found patients who took Paxil 25% of the time they took tamoxifen were 24 per cent more likely to die from breast cancer than subjects who didn’t use Paxil.

Patients who took Paxil for 75% of their tamoxifen use were more than 90 per cent more likely to die!

Read my full story on this worrisome development that could threaten the safety of air travelers: http://www.naturalnews.com/028514_antidepressant_drugs_pilots.html

Here’s a freebie for you from my new book…
In my opinion, the optimal condition for a body would include the following:
Starting each day feeling well rested and fully re-energised
Going through the day without peaks and troughs in your mental capacity or physical energy, capable of being fully productive for 16 hours
Mentally alert with good recall on persons, data and events, with high capacity to quick absorb, remember and apply new data in any field of interest
Able to competently execute all physical and mental tasks relevant to your age, gender, build and lifestyle
Maintaining a fully functioning body that delivers a healthy life without degenerative disease for 4-6 times the growth period
To live a healthy life for 4-6 times the growth period puts our lifespan somewhere between 100 and 150 years of age.
That being the case, how are we being short changed?

New drug spoof http://www.youtube.com/watch?v=JlmEc8rd_Nw&

Australian psychiatrist Patrick McGorry’s “Psychosis Risk Syndrome” has been shot down as “too risky, ill-conceived and potentially harmful” by the head of psychiatry’s Diagnostic & Statistical Manual of Mental Disorders (DSM-IV), Allen Frances. http://www.psychologytoday.com/blog/dsm5-in-distress/201003/dsm5-psychosis-risk-syndrome-far-too-risky

Millions of children have been injected with a vaccine that contains a pig virus that wasn’t supposed to be in the vaccine.

Federal health authorities recommended Monday that doctors suspend using Rotarix, one of two vaccines licensed in the United States against rotavirus, saying the vaccine is contaminated with material from a pig virus.

“There is no evidence at this time that this material poses a safety risk,” Food and Drug Administration Commissioner Dr. Margaret Hamburg told reporters in a conference call.

Rotarix, made by GlaxoSmithKline, was approved by the FDA in 2008. The contaminant material is DNA from porcine circovirus 1, a virus from pigs that is not known to cause disease in humans or animals, Hamburg said.

About 1 million children in the United States and about 30 million worldwide have gotten Rotarix vaccine, she said.

Rotavirus disease kills more than 500,000 infants around the world each year, primarily in low- and middle-income countries, she said. Before rotavirus vaccine became available, the disease was blamed for more than 50,000 hospitalizations and several dozen deaths per year in the United States, she said.

The FDA learned about the contamination after an academic research team using a novel technique to look for viruses in a range of vaccines found the material in GlaxoSmithKline’s product and told the company, Hamburg said. The drug maker confirmed its presence in both the cell bank and the seed from which the vaccine is derived, suggesting its presence from the early stages of vaccine development, she said. The FDA then confirmed the drug maker’s findings.

GlaxoSmithKline emphasized Monday that the pig virus is not known to cause illness in humans, saying “it is found in everyday meat products and is frequently eaten with no resulting disease or illness.”

“No safety issue has been identified by external agencies or GSK,” Thomas Breuer, the drug maker’s chief medical officer, said in a written statement. “GSK is committed to patient safety and to the highest manufacturing standards for all our vaccines and medicines. We are already working closely and discussing this finding with regulatory agencies around the world.”

Another vaccine, RotaTeq, is made by Merck and was approved in 2006. There is no evidence that the Merck product is affected, Hamburg said. Both vaccines are given by mouth to infants to prevent rotavirus disease, which is marked by severe diarrhea and dehydration.

Asked whether Merck would be able to meet the nation’s demand, Merck spokeswoman Pam Eisele said, “Obviously, we will work with the … FDA to evaluate supply needs.”

In the next four to six weeks, the drug agency will convene an advisory committee to make recommendations and seek input on the use of new techniques for identifying viruses in vaccine, Hamburg said.

“We’re not pulling it from the market, we’re just suspending its use during this period while we’re collecting more information,” she said. “It should not be in this vaccine product and we want to understand how it got there. It’s not an easy call and we spent many long hours debating the pros and cons but, because we have an alternative product and because the background rates of this disease are not so severe in this country, we felt that the judicious thing to do was to take a pause, to really ask the critical questions about what this material was doing in the vaccine, how it got there.”

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, said “a substantial amount” of the DNA was found in the vaccine. But, he stressed, “there is no evidence that it causes any disease. … There is no evidence that it ever does anything.”

The research group that discovered the contamination has asked not to be identified pending its paper’s publication in a scientific journal, Hamburg said.

Anyone who has already received a dose of Rotarix should switch to the Merck product for the next two doses, Hamburg said. Preliminary testing of the Merck product has found no evidence of the porcine circovirus 1 DNA, she said. Doctors should be able to tell parents which of the two products their children received, she said.

Hamburg stressed that the suspension applies only to the United States. Public health officials in countries where the incidence of rotavirus is more severe may decide that the benefits of continuing to use the vaccine outweigh any concerns raised by the contamination, she said. “Such a decision would be very understandable,” she added.

A similar virus, porcine circovirus 2, also does not cause disease in humans, but it does cause disease in its pig host, Hamburg said.

http://edition.cnn.com/2010/HEALTH/03/22/rotavirus.vaccine/?hpt=T2

Surprise surprise, surprise. If you give a kid speed to suppress the symptoms of a chemical imbalance that does not exist, they do worse in school!
Professor Lou Landau was co-author of the WA-based research which investigated the effectiveness of drugs now widely used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children.
The principal medical adviser to the West Australian Department of Health said he did not expect such a strongly negative result.
“Yes, we weren’t anticipating that significant effect,” Prof Landau told reporters on Wednesday.
“… or the significant lack of effect of the medication.”
Prof Landau and fellow researchers pulled data from the nation’s long-term Raine Study to assess the health, and other, outcomes of 131 children with ADHD among more than 2,800 Australian families.
It showed how those using conventional ADHD drugs, such as Ritalin and dexamphetamine, had significantly poorer educational outcomes than children with ADHD not using the stimulants.
The drugs were also linked to a “trend toward slightly higher depression scores”, the study found, along with a potentially long-term risk factor for heart disease.
Children using ADHD drugs were found to have elevated diastolic blood pressure – which is the minimum pressure in the arteries when the heart is at rest.
Prof Landau said this side-effect was known though it was previously thought to occur in children “while on the medication and it drops down when you stop”.
“That was the difference that this study showed … it was having an effect on the blood vessels that persisted,” he said.
When it came to educational performance, children on ADHD drugs were shown to be significantly worse off that those with unmedicated or no longer medicated ADHD.
This effect was present even after researchers accounted for the fact that ADHD children with the worst symptoms were most likely to be prescribed the drugs.
“In children with ADHD, ever receiving stimulant medication was found to increase the odds of being identified as performing below age-level by a classroom teacher by a factor of 10.5 times,” the study found.
Overall, there was “little long-term benefit of stimulant medication” for ADHD children, the study concluded.